# OnCo record prospect-prostvac (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/prospect-prostvac/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "prospect-prostvac", "NCT01322490" ;
  schema:name "PROSPECT"@en ;
  schema:alternateName "PROSPECT"@en, "BNIT-PRV-301"@en, "PROSTVAC phase 3"@en ;
  schema:description "The prostate cancer vaccine that looked like it added eight and a half months of life in a small trial added nothing in a big one."@en ;
  schema:url <https://onco.cc/trials/prospect-prostvac/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT01322490>, <https://doi.org/10.1200/JCO.18.02031> ;
  onco:status "negative" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-mcrpc/> ;
  onco:technologies <https://onco.cc/technologies/shared-antigen-vaccine/> ;
  onco:drugs <https://onco.cc/drugs/prostvac/> ;
  onco:companies <https://onco.cc/companies/bavarian-nordic/> ;
  onco:terms <https://onco.cc/terms/castration-resistance/>, <https://onco.cc/terms/psa/> ;
  onco:trials <https://onco.cc/trials/impact-sipuleucel-t/>, <https://onco.cc/trials/ca184-043-ipilimumab/> .